Synthesis and Characterization of Celecoxib Derivatives as Possible Anti-Inflammatory, Analgesic, Antioxidant, Anticancer and Anti-HCV Agents
dc.authorid | senkardes, sevil/0000-0002-0523-459X | |
dc.authorid | Küçükgüzel, Ş.Güniz/0000-0001-9405-8905 | |
dc.authorid | University, Aydin Adnan Menderes/0000-0002-9325-3757 | |
dc.authorid | Ozakpınar, Ozlem Bingol/0000-0003-0287-5639 | |
dc.authorid | AKTAY, Goknur/0000-0002-1646-8674 | |
dc.authorwosid | Gürsoy, Şule/JPW-8593-2023 | |
dc.authorwosid | senkardes, sevil/AAA-3948-2020 | |
dc.authorwosid | Küçükgüzel, Ş.Güniz/AAQ-8954-2021 | |
dc.authorwosid | University, Aydin Adnan Menderes/Z-2790-2019 | |
dc.authorwosid | Ozakpınar, Ozlem Bingol/ABI-4144-2020 | |
dc.authorwosid | Ozakpinar, Ozlem Bingol/ACB-1160-2022 | |
dc.contributor.author | Kucukguzel, S. Guniz | |
dc.contributor.author | Coskun, Inci | |
dc.contributor.author | Aydin, Sevil | |
dc.contributor.author | Aktay, Goknur | |
dc.contributor.author | Gursoy, Sule | |
dc.contributor.author | Cevik, Ozge | |
dc.contributor.author | Ozakpinar, Ozlem Bingol | |
dc.date.accessioned | 2024-08-04T20:37:29Z | |
dc.date.available | 2024-08-04T20:37:29Z | |
dc.date.issued | 2013 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | A series of novel N-(3-substituted aryl/alkyl-4-oxo-1,3-thiazolidin-2-ylidene)-4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamides 2a-e were synthesized by the addition of ethyl alpha-bromoacetate and anhydrous sodium acetate in dry ethanol to N-(substituted aryl/alkylcarbamothioyl)-4-[5-(4-methylphenyl)-3-(trifluoro-methyl)- 1H-pyrazol-1-yl] benzene sulfonamides 1a-e, which were synthesized by the reaction of alkyl/aryl isothiocyanates with celecoxib. The structures of the isolated products were determined by spectral methods and their anti-inflammatory, analgesic, antioxidant, anticancer and anti-HCV NS5B RNA-dependent RNA polymerase (RdRp) activities evaluated. The compounds were also tested for gastric toxicity and selected compound 1a was screened for its anticancer activity against 60 human tumor cell lines. These investigations revealed that compound 1a exhibited anti-inflammatory and analgesic activities and further did not cause tissue damage in liver, kidney, colon and brain compared to untreated controls or celecoxib. Compounds 1c and 1d displayed modest inhibition of HCV NS5B RdRp activity. In conclusion, N-(ethylcarbamothioyl)-4-[5-(4-methylphenyl)- 3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide (1a) may have the potential to be developed into a therapeutic agent. | en_US |
dc.description.sponsorship | Research Fund of Marmara University [SAG-A-310510-0175]; National Institute of Health [CA153147] | en_US |
dc.description.sponsorship | We wish to thank the National Cancer Institute for in vitro pharmacological screening. This work was generously supported by the Research Fund of Marmara University, project number: SAG-A-310510-0175 to S. G. K. HCV NS5B inhibition studies were supported by the National Institute of Health Research Grant CA153147 to N.K.-B. The authors are grateful to Jurgen Gross from the Institute of Organic Chemistry, University of Heidelberg, for his generous help on obtaining HR-EI mass spectra of the synthesized compounds. | en_US |
dc.identifier.doi | 10.3390/molecules18033595 | |
dc.identifier.endpage | 3614 | en_US |
dc.identifier.issn | 1420-3049 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 23519201 | en_US |
dc.identifier.scopus | 2-s2.0-84875601300 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 3595 | en_US |
dc.identifier.uri | https://doi.org/10.3390/molecules18033595 | |
dc.identifier.uri | https://hdl.handle.net/11616/95994 | |
dc.identifier.volume | 18 | en_US |
dc.identifier.wos | WOS:000316611700079 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Mdpi | en_US |
dc.relation.ispartof | Molecules | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | anti-inflammatory | en_US |
dc.subject | anticancer | en_US |
dc.subject | celecoxib | en_US |
dc.subject | hepatitis C NS5B | en_US |
dc.subject | sulfonylthiourea | en_US |
dc.title | Synthesis and Characterization of Celecoxib Derivatives as Possible Anti-Inflammatory, Analgesic, Antioxidant, Anticancer and Anti-HCV Agents | en_US |
dc.type | Article | en_US |